Literature DB >> 6334099

2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation.

Y Sidi, B S Mitchell.   

Abstract

Inherited deficiency of the enzyme purine nucleoside phosphorylase (PNP) results in selective and severe T lymphocyte depletion which is mediated by its substrate, 2'-deoxyguanosine. This observation provides a rationale for the use of PNP inhibitors as selective T cell immunosuppressive agents. We have studied the relative effects of the PNP inhibitor 8-aminoguanosine on the metabolism and growth of lymphoid cell lines of T and B cell origin. We have found that 2'-deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels. Growth inhibition and GTP accumulation are prevented by hypoxanthine or adenine, but not by 2'-deoxycytidine. 8-Aminoguanosine appears to effectively inhibit extracellular PNP activity; thus, it prolongs the extracellular half-life of 2'-deoxyguanosine and guanosine, but does not completely inhibit intracellular PNP activity in these lymphoid cells. As a result, 2'-deoxyguanosine and guanosine are phosphorolyzed and actively salvaged within the cell, accounting for the accumulation of GTP. Partial inhibition of PNP activity in vivo, therefore, may lead to nonselective cellular toxicity by a mechanism independent of dGTP accumulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334099      PMCID: PMC425341          DOI: 10.1172/JCI111580

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.

Authors:  L J Gudas; B Ullman; A Cohen; D W Martin
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

2.  Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency.

Authors:  T S Chan
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

3.  Measurement of free nucleotides in cultured human lymphoid cells using high pressure liquid chromatography.

Authors:  D P Brenton; K H Astrin; M K Cruikshank; J E Seegmiller
Journal:  Biochem Med       Date:  1977-06

4.  Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties.

Authors:  E W Holmes; J A McDonald; J M McCord; J B Wyngaarden; W N Kelley
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

5.  Multiple mechanisms of regulation of purine biosynthesis de novo in intact tumor cells.

Authors:  A S Bagnara; A A Letter; J F Henderson
Journal:  Biochim Biophys Acta       Date:  1974-12-20

6.  Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.

Authors:  A Cohen; L J Gudas; A J Ammann; G E Staal; D W Martin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

7.  Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Authors:  A Cohen; D Doyle; D W Martin; A J Ammann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  Characterization of a guanine-sensitive mutant defective in adenylo-succinate synthetase activity.

Authors:  A S Tu; D Patterson
Journal:  J Cell Physiol       Date:  1978-07       Impact factor: 6.384

9.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

10.  Guanosine metabolism in Novikoff hepatoma cells: isolation and characterization of guanosine resistant variants.

Authors:  R A May; P Hoffee
Journal:  Arch Biochem Biophys       Date:  1978-10       Impact factor: 4.013

View more
  7 in total

1.  Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.

Authors:  J E Damen; M A Spearman; A H Greenberg; J A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides.

Authors:  D A Glesne; F R Collart; E Huberman
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

3.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

4.  Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.

Authors:  G J Mann; R M Fox
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  Staphylococcus aureus Multiplexes Death-Effector Deoxyribonucleosides to Neutralize Phagocytes.

Authors:  Eshraq Tantawy; Nicoletta Schwermann; Tjorven Ostermeier; Annette Garbe; Heike Bähre; Marius Vital; Volker Winstel
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

7.  Cytotoxicity of guanine-based degradation products contributes to the antiproliferative activity of guanine-rich oligonucleotides.

Authors:  Nan Zhang; Tao Bing; Xiangjun Liu; Cui Qi; Luyao Shen; Linlin Wang; Dihua Shangguan
Journal:  Chem Sci       Date:  2015-04-07       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.